While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.
Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
The railways heritage lines that are part of the UNESCO-accorded sites list include Darjeeling Himalayan Railway, Nilgiri Mountain Railway, and Kalka Shimla Railway.
'Opening everything is not appropriate ... everyone has been saying the third wave is a couple of days away'
The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.
It should stop what it is deliberately doing to the NGO sector and let it operate as freely as the rest of the private sector, asserts Aakar Patel.
States are planning to pass resolutions in their legislative assemblies; however, such tactics will be used as the last resort if the Centre continues to stall allocations.
About 50 lakh people have registered themselves on the Co-WIN portal, without any system glitch, since the window opened Monday morning, the Centre said Tuesday, adding that over 2.08 lakh beneficiaries above 60 or those aged 45-60 with comorbidities have received the first dose of COVID-19 vaccine till this afternoon.
"The theme of tomorrow's meeting is 'Economic Policy Reform, Road Ahead'. The prime minister will make opening remarks. There are 15 invitees who will make their presentations before the prime minister," a senior government official said.
'With over 50 per cent of medical seats reserved for those who have the ability to pay a fee ranging from Rs 50 lakh to Rs 1.5 crore for a five-year MBBS course and quotas in accordance with affirmative policies in government colleges, the band of seats available for the not-so-rich and non-OBCs is very narrow.'
Can the newly-minted Jal Shakti ministry bring water to some 19 crore Indian households that have never had taps or heard the sound of flowing water, wonders Vinayak Chatterjee.
'Transparency, privacy and security have been the core design principle of Aarogya Setu. Opening the source code to developer community signifies Government of India continuing principal to these commitments'
Her decision is being seen in the political circle as an outcome of the heightened tussle between the TMC and the BJP in West Bengal.
Raje, who has been facing mounting opposition pressure to quit in connection with the 'Lalitgate', arrived around 9:30 am.
Raje is likely to meet the BJP top brass amidst mounting opposition pressure for her resignation.
Out of the total amount, Rs 17,359.77 crore is aircraft loan, while Rs 31,517.04 crore is working capital loan.
The Prime Minister's Office has decided to set up a panel, led by former chief statistician T C A Anant, to deliberate on whether the enterprise-level quarterly data, which is released by the labour bureau, should be discontinued.
On the back of ongoing reforms and stress on manufacturing, India. he said, can look for much bigger share in global exports.
While there is a continuous increasing trend in COVID-19 cases and deaths globally, particularly in America and Europe and the situation in the world is becoming worrisome, in contrast the scene in India is satisfying as the cases and deaths are declining, Dr V K Paul, member (health) at NITI Aayog, told a press conference.
India's water future remains very bleak. The monsoon season, which once extended to 4 months, is now down to less than 30 days of heavy rain.
The sero-surveillance started on June 3 and 6,936 samples out of an estimated 8,870 were collected from slum and non-slum population of three civic wards -- R-North, M-West and F-North -- in the first half of July.
The NITI Aayog, in a concept note floated a few months back, had suggested three models of procurement but the Centre, at least for the time being, has decided to rely on existing PSS schemes along with giving states the option of choosing Bhawantar Bhugtan for oilseeds.
Addressing a press conference, NITI Aayog Member (Health) Dr V K Paul said the question of the third wave keeps coming up because the population is still 'very vulnerable' to the infection.
Zomato has the potential to be an equally important milestone for Indian equity markets, notes Akash Prakash.
CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.
The Auto Component Manufacturers Association of India on Wednesday sought reduction in GST rate to a uniform level of 18 per cent for the entire automobile industry to stimulate demand and help save around 10 lakh jobs, which are at risk due to prolonged slowdown in vehicle sales.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.
The government said it had been evaluating the implementation of the decentralised model of vaccination since its launch on May 1 and that the decision to centralise it again was taken after detailed deliberations and following requests by some states, amid claims by the Opposition that the policy change was due to the Supreme Court's intervention.
The standoff between the government and the opposition in Parliament has showed no signs of easing after it erupted on the opening day of the Monsoon session on July 19.
Union Health Minister Harsh Vardhan on Monday said 28,252 cases of mucormycosis have so far been reported from 28 states/UTs in the country, of which 86 per cent cases have a history of COVID-19 and 62.3 per cent with a history of diabetes.
Apart from the 1.1 crore doses of Covishield being procured from the Serum Institute of India, 55 lakh doses of indigenously developed Covaxin were being obtained from Bharat Biotech, Union Health Secretary Rajesh Bhushan said at a press conference.
As the SARS-CoV2 evolves and mutates further, it is necessary to be prepared for new waves, Principal Scientific Adviser K VijayRaghavan cautioned on Wednesday, even as he said ferocity of the second wave of coronavirus in the country was not predicted.
More than 6.5 crore vaccine doses have been administered across the country so far to frontline workers, healthcare workers, those above 60 and for people aged above 45 with specified co-co-morbid conditions.
While it was not directly suggested that the COVID-19 pandemic was related to biological warfare, it is significant that the government is exhorting military laboratories to work concertedly on biological defence.
In a resolution passed at its national assembly in Haridwar, the SJM said the Modi government's proposed strategic divestment of PSEs was an "imprudent business decision" and "against national interest".
A steady decline in new COVID-19 cases has been recorded in India for the last 20 days, with 24 states witnessing a dip in active cases since the last week, the Union health ministry said.
'With nearly double the market share of our nearest competitor, we are shaping the digital transformation journey of close to 1,000 clients in India.'
'Scientifically the effect and change of Delta plus has to be watched through our INSACOG system. This has to be detected and we have to see its presence in the country'
"Despite the high number of cases reported so far, we have been able to contain the spread to under 2 pc of population," said Health Ministry Joint Secretary Lav Agarwal.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances